What is the address of Dr. Veerle Gregoor Anesthesie?

The registered office of Dr. Veerle Gregoor Anesthesie is located at Rattenborgstraat 8, 3473 Kortenaken.

Is Dr. Veerle Gregoor Anesthesie still active?

Yes. According to the CBE (31 October 2026) Dr. Veerle Gregoor Anesthesie is active, legal situation “Normale toestand”, started on 16 October 2020.

Is Dr. Veerle Gregoor Anesthesie registered on Peppol?

Yes, Dr. Veerle Gregoor Anesthesie is registered on the Peppol network with ID 0208:0756678687.

What is the enterprise number of Dr. Veerle Gregoor Anesthesie?

The enterprise number of Dr. Veerle Gregoor Anesthesie is BE0756678687.

When was Dr. Veerle Gregoor Anesthesie founded?

Dr. Veerle Gregoor Anesthesie was founded on 16 October 2020.

Who are the directors of Dr. Veerle Gregoor Anesthesie?

According to the 2025 annual accounts, the directors of Dr. Veerle Gregoor Anesthesie are: Veerle Petra Gregoor.

Is Dr. Veerle Gregoor Anesthesie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 October 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Veerle Gregoor Anesthesie make in 2025?

Dr. Veerle Gregoor Anesthesie posted a profit after taxes of € 111,538 in financial year 2025.

What is the revenue of Dr. Veerle Gregoor Anesthesie?

As a small company, Dr. Veerle Gregoor Anesthesie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 149,908.

Dr. Veerle Gregoor Anesthesie (Private Limited)

Dossier Dr. Veerle Gregoor Anesthesie, printed on 1 November 2026 from databakkes.be/en/0756678687/dr-veerle-gregoor-anesthesie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Veerle Gregoor Anesthesie from Kortenaken, company number BE0756678687, closed financial year 2025 with a result of € 111,538 after tax. For that financial year Dr. Veerle Gregoor Anesthesie recorded a gross margin of € 149,908 and equity of € 2,000. Compared with financial year 2024, the result moved from € 123,194 to € 111,538. The company is profitable. The buffer shrank hard: equity is 98 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 19, 2026.

What it is worth Shrank hard

€ 2,000

▼ 98% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 111,538

▼ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 239,183

▼ 10% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 234,732 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 895

▼ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 18,395

▲ € 16,373 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 127,193 Gross margin 2022: € 127,193 First fiscal year in the series	€ 137,147 Gross margin 2023: € 137,147 ▲ 8% vs 2022 (€ 127,193) Favourable step	€ 164,630 Gross margin 2024: € 164,630 ▲ 20% vs 2023 (€ 137,147) Favourable step	€ 149,908 Gross margin 2025: € 149,908 ▼ 9% vs 2024 (€ 164,630) Unfavourable step	▼ 9%
Profit after taxes	€ 97,353 Profit after taxes 2022: € 97,353 First fiscal year in the series	€ 108,439 Profit after taxes 2023: € 108,439 ▲ 11% vs 2022 (€ 97,353) Favourable step	€ 123,194 Profit after taxes 2024: € 123,194 ▲ 14% vs 2023 (€ 108,439) Favourable step	€ 111,538 Profit after taxes 2025: € 111,538 ▼ 9% vs 2024 (€ 123,194) Unfavourable step	▼ 9%
Equity	€ 260,024 Equity 2022: € 260,024 First fiscal year in the series	€ 367,663 Equity 2023: € 367,663 ▲ 41% vs 2022 (€ 260,024) Favourable step	€ 125,194 Equity 2024: € 125,194 ▼ 66% vs 2023 (€ 367,663) Unfavourable step	€ 2,000 Equity 2025: € 2,000 ▼ 98% vs 2024 (€ 125,194) Unfavourable step	▼ 98%
Total debts	€ 38,600 Total debts 2022: € 38,600 First fiscal year in the series	€ 996 Total debts 2023: € 996 ▼ 97% vs 2022 (€ 38,600) Favourable step	€ 173,358 Total debts 2024: € 173,358 ▲ € 172,362 vs 2023 (€ 996) Unfavourable step	€ 285,200 Total debts 2025: € 285,200 ▲ 65% vs 2024 (€ 173,358) Unfavourable step	▲ 65%
Cash	€ 247,901 Cash 2022: € 247,901 First fiscal year in the series	€ 298,524 Cash 2023: € 298,524 ▲ 20% vs 2022 (€ 247,901) Favourable step	€ 266,106 Cash 2024: € 266,106 ▼ 11% vs 2023 (€ 298,524) Unfavourable step	€ 239,183 Cash 2025: € 239,183 ▼ 10% vs 2024 (€ 266,106) Unfavourable step	▼ 10%
Retained profit	€ 258,024 Retained profit 2022: € 258,024 First fiscal year in the series	€ 365,663 Retained profit 2023: € 365,663 ▲ 42% vs 2022 (€ 258,024) Favourable step	€ 123,194 Retained profit 2024: € 123,194 ▼ 66% vs 2023 (€ 365,663) Unfavourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 123,194) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 800 Dividend 2023: € 800 Unchanged (€ 0) Unchanged	€ 365,663 Dividend 2024: € 365,663 ▲ € 364,863 vs 2023 (€ 800) Unchanged	€ 234,732 Dividend 2025: € 234,732 ▼ 36% vs 2024 (€ 365,663) Unchanged	▼ 36%
Balance sheet total	€ 298,625 Balance sheet total 2022: € 298,625 First fiscal year in the series	€ 368,660 Balance sheet total 2023: € 368,660 ▲ 23% vs 2022 (€ 298,625) Unchanged	€ 298,552 Balance sheet total 2024: € 298,552 ▼ 19% vs 2023 (€ 368,660) Unchanged	€ 287,200 Balance sheet total 2025: € 287,200 ▼ 4% vs 2024 (€ 298,552) Unchanged	▼ 4%

Key figures of Dr. Veerle Gregoor Anesthesie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Veerle Gregoor Anesthesie?

What happened at Dr. Veerle Gregoor Anesthesie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 19, 2026 New annual accounts for financial year 2025: profit of € 111,538 (▼ 9% vs 2024). Source: NBB ↗
Oct 16, 2020 New establishment in Kortenaken. KBO
Oct 16, 2020 Start of the company according to the CBE. KBO
2020 Veerle Petra Gregoor became a director. NBB

In short

From € 97,353 profit in 2022 to € 111,538 profit in 2025.

Paid € 127,784 in corporate taxes since 2022.

Best year ever: 2024, with € 123,194 profit.

Paid out € 601,196 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Veerle Petra Gregoor

Dr. Veerle Gregoor Anesthesie

Behind Dr. Veerle Gregoor Anesthesie is Veerle Petra Gregoor.

Directors

According to the 2025 annual accounts

Veerle Petra Gregoor

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Rattenborgstraat 8

3473 Kortenaken

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0756.678.687
VAT number: BE 0756.678.687
Registered office: Rattenborgstraat 8, 3473 Kortenaken
Names & denominations: Dr. Veerle Gregoor Anesthesie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 16 October 2020
Peppol: Active · Active since 2 Sept 2025
Contact: [email protected]

View on CBE Public ↗ Annual accounts (NBB) ↗